We describe a patient with the previously unreported association of ch
ronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia
gravis (MG). Immunosuppressive treatment with azathioprine and prednis
one achieved clinical and electrophysiological remission of MG and imp
rovement of CIDP. As ophthalmoplegia occurs infrequently in CIDP, the
possibility of MG should be considered when this sign is present in a
patient with CIDP. Since current therapy with corticosteroids, plasma
exchange and other immunomodulating agents is effective against both d
iseases, their association may be undereported.